Pfizer (PFE) Tops Q1 EPS by 29c, Beats on Revenue; Offers FY24 Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.93 +0.68%
Revenue Growth %: -4.6%
Financial Fact:
Restructuring charges and certain acquisition-related costs: 531M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -4.6%
Financial Fact:
Restructuring charges and certain acquisition-related costs: 531M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.82, $0.29 better than the analyst estimate of $0.53. Revenue for the quarter came in at $14.9 billion versus the consensus estimate of $14.04 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.15-$2.35, versus the consensus of $2.21. Pfizer sees FY2024 revenue of $58.5-61.5 billion, versus the consensus of $60 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Progress Software completes $400M acquisition of Domo's data platform
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
